SYMPTOMATIC NEUROGENIC ORTHOSTATIC HYPOTENSION

Clinical trials for SYMPTOMATIC NEUROGENIC ORTHOSTATIC HYPOTENSION explained in plain language.

Never miss a new study

Get alerted when new SYMPTOMATIC NEUROGENIC ORTHOSTATIC HYPOTENSION trials appear

Sign up with your email to follow new studies for SYMPTOMATIC NEUROGENIC ORTHOSTATIC HYPOTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for managing dizzy spells in rare neurological disease

Symptom relief Ongoing

This study is testing whether a drug called ampreloxetine can safely and effectively reduce symptoms of low blood pressure when standing in people with multiple system atrophy (MSA). About 102 participants will take the drug for 20 weeks, then some will be randomly switched to a …

Matched conditions: SYMPTOMATIC NEUROGENIC ORTHOSTATIC HYPOTENSION

Phase: PHASE3 • Sponsor: Theravance Biopharma • Aim: Symptom relief

Last updated Mar 31, 2026 12:11 UTC

SYMPTOMATIC NEUROGENIC ORTHOSTATIC HYPOTENSION

Get alerted when new SYMPTOMATIC NEUROGENIC ORTHOSTATIC HYPOTENSION trials appear

New hope for managing dizzy spells in rare neurological disease